J0150 — Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)
J0150 is a HCPCS Level II code for injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270). It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2014 and is not valid on new claims.
This code has been terminated
CMS terminated J0150 on December 31, 2014. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J0150
- Long descriptor
- Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)
- Short descriptor
- Injection adenosine 6 mg
- Added
- January 1, 1994
- Terminated
- December 31, 2014
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J0150
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0150 is not quite right, the correct code is very often within a few positions of it.
- J0132Injection, acetylcysteine, 100 mg
- J0133Injection, acyclovir, 5 mg
- J0134Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg
- J0135Injection, adalimumab, 20 mgterminated
- J0136Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg
- J0137Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg
- J0138Injection, acetaminophen 10 mg and ibuprofen 3 mg
- J0139Injection, adalimumab, 1 mg
- J0151Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)terminated
- J0153Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)
- J0162Injection, epinephrine (fresenius), not therapeutically equivalent to j0165, 0.1 mg
- J0163Injection, epinephrine in sodium chloride (endo), 0.1 mg
- J0164Injection, epinephrine in sodium chloride (baxter), 0.1 mg
- J0165Injection, epinephrine, not otherwise specified, 0.1 mg
- J0166Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mg
- J0167Injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 mg
Questions about J0150
What is HCPCS code J0150?
J0150 is a HCPCS Level II code for injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270). It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J0150?
The CMS HCPCS file marks J0150 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
Is J0150 still valid?
No. J0150 was terminated on December 31, 2014 and should not be used on new claims.